Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis.
Journal: Bone marrow transplantation
Published: April 30, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Journal: Leukemia research
Published: March 18, 2025
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 12, 2025
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).
Journal: Cancers
Published: October 05, 2024
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: June 19, 2024
Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.
Journal: Bone marrow transplantation
Published: June 18, 2024
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation.
Journal: Leukemia research
Published: April 30, 2024
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 23, 2024
CML and the WHO: Why?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2023
WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens.
Journal: Leukemia & lymphoma
Published: August 03, 2023
Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Journal: Transplantation and cellular therapy
Published: March 02, 2023
Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring.
Journal: Frontiers in pharmacology
Published: December 18, 2022
Last Updated: 09/26/2026